Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Interferon in Children With High-Risk Melanoma
NCT00539591Phase 2Active, not recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- May 2008
- Primary completion
- Jun 2015
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2b in Malignant Melanoma (MM), sponsored by St. Jude Children's Research Hospital. Started May 2008; status: active, not recruiting.
02
Drugs
peginterferon alfa-2b
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00539591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00539591.